Elio Riboli

Elio Riboli

Imperial College London

H-index: 199

Europe-United Kingdom

Professor Information

University

Imperial College London

Position

Professor of Cancer Epidemiology

Citations(all)

228237

Citations(since 2020)

94851

Cited By

172678

hIndex(all)

199

hIndex(since 2020)

109

i10Index(all)

1051

i10Index(since 2020)

874

Email

University Profile Page

Imperial College London

Research & Interests List

epidemiology

genetics

cancer

public health

Top articles of Elio Riboli

Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study

BackgroundThe association of fitness with cancer risk is not clear.MethodsWe used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of lung, colorectal, endometrial, breast, and prostate cancer in a subset of UK Biobank participants who completed a submaximal fitness test in 2009-12 (N = 72,572). We also investigated relationships using two-sample Mendelian randomisation (MR), odds ratios (ORs) were estimated using the inverse-variance weighted method.ResultsAfter a median of 11 years of follow-up, 4290 cancers of interest were diagnosed. A 3.5 ml O2⋅min−1⋅kg−1 total-body mass increase in fitness (equivalent to 1 metabolic equivalent of task (MET), approximately 0.5 standard deviation (SD)) was associated with lower risks of endometrial (HR = 0.81, 95% CI: 0.73–0.89), colorectal (0.94, 0.90–0.99), and breast cancer (0.96, 0.92–0.99). In …

Authors

Eleanor L Watts,Tomas I Gonzales,Tessa Strain,Pedro F Saint-Maurice,D Timothy Bishop,Stephen J Chanock,Mattias Johansson,Temitope O Keku,Loic Le Marchand,Victor Moreno,Polly A Newcomb,Christina C Newton,Rish K Pai,Mark P Purdue,Cornelia M Ulrich,Karl Smith-Byrne,Bethany Van Guelpen,Henrik Grönberg,Nora Pashayan,Johanna Schleutker,Demetrius Albanes,Stephanie J Weinstein,Alicja Wolk,Catharine ML West,Lorelei A Mucci,Géraldine Cancel-Tassin,Stella Koutros,Karina Dalsgaard Sørensen,Eli Marie Grindedal,David E Neal,Freddie C Hamdy,Jenny L Donovan,Ruth C Travis,Robert J Hamilton,Sue Ann Ingles,Barry S Rosenstein,Yong-Jie Lu,Graham G Giles,Robert J MacInnis,Adam S Kibel,Ana Vega,Manolis Kogevinas,Kathryn L Penney,Jong Y Park,Janet L Stanford,Cezary Cybulski,Børge G Nordestgaard,Sune F Nielsen,Hermann Brenner,Christiane Maier,Jeri Kim,Esther M John,Manuel R Teixeira,Susan L Neuhausen,Kim De Ruyck,Azad Razack,Lisa F Newcomb,Davor Lessel,Radka Kaneva,Nawaid Usmani,Frank Claessens,Paul A Townsend,Jose Esteban Castelao,Monique J Roobol,Florence Menegaux,Kay-Tee Khaw,Lisa Cannon-Albright,Hardev Pandha,Stephen N Thibodeau,David J Hunter,Peter Kraft,William J Blot,Elio Riboli

Journal

British Journal of Cancer

Published Date

2024/1/31

BMI and breast cancer risk around age at menopause

BackgroundA high body mass index (BMI, kg/m2) is associated with decreased risk of breast cancer before menopause, but increased risk after menopause. Exactly when this reversal occurs in relation to menopause is unclear. Locating that change point could provide insight into the role of adiposity in breast cancer etiology.MethodsWe examined the association between BMI and breast cancer risk in the Premenopausal Breast Cancer Collaborative Group, from age 45 up to breast cancer diagnosis, loss to follow-up, death, or age 55, whichever came first. Analyses included 609,880 women in 16 prospective studies, including 9956 who developed breast cancer before age 55. We fitted three BMI hazard ratio (HR) models over age-time: constant, linear, or nonlinear (via splines), applying piecewise exponential additive mixed models, with age as the primary time scale. We divided person-time into four strata …

Authors

Ann Von Holle,Hans-Olov Adami,Laura Baglietto,Amy Berrington,Kimberly A Bertrand,William Blot,Yu Chen,Jessica Clague DeHart,Laure Dossus,A Heather Eliassen,Agnes Fournier,Montse Garcia-Closas,Graham Giles,Marcela Guevara,Susan E Hankinson,Alicia Heath,Michael E Jones,Corinne E Joshu,Rudolf Kaaks,Victoria A Kirsh,Cari M Kitahara,Woon-Puay Koh,Martha S Linet,Hannah Lui Park,Giovanna Masala,Lene Mellemkjaer,Roger L Milne,Katie M O'Brien,Julie R Palmer,Elio Riboli,Thomas E Rohan,Martha J Shrubsole,Malin Sund,Rulla Tamimi,Sandar Tin Tin,Kala Visvanathan,Roel CH Vermeulen,Elisabete Weiderpass,Walter C Willett,Jian-Min Yuan,Anne Zeleniuch-Jacquotte,Hazel B Nichols,Dale P Sandler,Anthony J Swerdlow,Minouk J Schoemaker,Clarice R Weinberg

Journal

Cancer Epidemiology

Published Date

2024/4/1

Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults

BackgroundUnderweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories.MethodsWe used data from 3663 population-based studies with 222 million participants that measured height and weight in representative samples of the general population. We used a Bayesian hierarchical model to estimate trends in the prevalence of different BMI categories, separately for adults (age ≥20 years) and school-aged children and adolescents (age 5–19 years), from 1990 to 2022 for 200 countries and territories. For adults, we report the individual and combined prevalence of underweight (BMI <18·5 kg/m2) and obesity (BMI ≥30 kg/m2). For school-aged children and …

Authors

Nowell H Phelps,Rosie K Singleton,Bin Zhou,Rachel A Heap,Anu Mishra,James E Bennett,Christopher J Paciorek,Victor PF Lhoste,Rodrigo M Carrillo-Larco,Gretchen A Stevens,Andrea Rodriguez-Martinez,Honor Bixby,James Bentham,Mariachiara Di Cesare,Goodarz Danaei,Archie W Rayner,Ana Barradas-Pires,Melanie J Cowan,Stefan Savin,Leanne M Riley,Carlos A Aguilar-Salinas,Jennifer L Baker,Amina Barkat,Zulfiqar A Bhutta,Francesco Branca,Roberta B Caixeta,Sarah Cuschieri,Farshad Farzadfar,Shubash Ganapathy,Nayu Ikeda,Violeta Iotova,Andre P Kengne,Young-Ho Khang,Avula Laxmaiah,Hsien-Ho Lin,Jun Ma,Jean Claude N Mbanya,J Jaime Miranda,Rajendra Pradeepa,Fernando Rodríguez-Artalejo,Maroje Sorić,Maria Turley,Limin Wang,Karen Webster-Kerr,Julie Aarestrup,Leandra Abarca-Gómez,Mohsen Abbasi-Kangevari,Ziad A Abdeen,Shynar Abdrakhmanova,Suhaila Abdul Ghaffar,Hanan F Abdul Rahim,Zulfiya Abdurrahmonova,Niveen M Abu-Rmeileh,Jamila Abubakar Garba,Benjamin Acosta-Cazares,Ishag Adam,Marzena Adamczyk,Robert J Adams,Seth Adu-Afarwuah,Wichai Aekplakorn,Kaosar Afsana,Shoaib Afzal,Valirie N Agbor,Imelda A Agdeppa,Javad Aghazadeh-Attari,Åsa Ågren,Hassan Aguenaou,Charles Agyemang,Mohamad Hasnan Ahmad,Noor Ani Ahmad,Ali Ahmadi,Naser Ahmadi,Nastaran Ahmadi,Imran Ahmed,Soheir H Ahmed,Wolfgang Ahrens,Gulmira Aitmurzaeva,Kamel Ajlouni,Hazzaa M Al-Hazzaa,Halima Al-Hinai,Badreya Al-Lahou,Jawad A Al-Lawati,Rajaa Al-Raddadi,Deena Al Asfoor,Huda M Al Hourani,Nawal M Al Qaoud,Monira Alarouj,Fadia AlBuhairan,Shahla AlDhukair,Maryam A Aldwairji,Sylvia Alexius,Mohamed M Ali,Anna V Alieva,Abdullah Alkandari,Ala'a Alkerwi,Buthaina M Alkhatib,Kristine Allin,Shaker A Alomary,Husam F Alomirah,Arwa M Alshangiti,Mar Alvarez-Pedrerol,Eman Aly,Deepak N Amarapurkar,Pilar Amiano Etxezarreta,John Amoah,Norbert Amougou,Philippe Amouyel,Lars Bo Andersen,Sigmund A Anderssen,Odysseas Androutsos,Lars Ängquist,Ranjit Mohan Anjana,Alireza Ansari-Moghaddam,Elena Anufrieva,Hajer Aounallah-Skhiri,Joana Araújo,Inger Ariansen,Tahir Aris,Raphael E Arku,Nimmathota Arlappa,Krishna K Aryal,Nega Assefa,Thor Aspelund,Felix K Assah,Batyrbek Assembekov,Maria Cecília F Assunção,May Soe Aung,Correia Júnior Marco Aurélio de Valois,Juha Auvinen,Mária Avdičová,Shina Avi,Kishwar Azad,Ana Azevedo,Mohsen Azimi-Nezhad,Fereidoun Azizi,Bontha V Babu,Flora Bacopoulou,Maja Bæksgaard Jørgensen,Azli Baharudin,Suhad Bahijri,Izet Bajramovic,Marta Bakacs,Nagalla Balakrishna,Yulia Balanova,Mohamed Bamoshmoosh,Maciej Banach,José R Banegas,Joanna Baran,Rafał Baran,Carlo M Barbagallo

Journal

The Lancet

Published Date

2024/2/29

Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort

Background Obesity and diabetes are associated inversely with low‐grade prostate cancer risk and affect steroid hormone synthesis but whether they modify each other's impact on prostate cancer risk remains unknown. Methods We examined the independent associations of diabetes, body mass index (BMI), ‘a body shape index’ (ABSI), hip index (HI), circulating testosterone, sex hormone binding globulin (SHBG) (per one standard deviation increase) and oestradiol ≥175 pmol/L with total prostate cancer risk using multivariable Cox proportional hazards models for UK Biobank men. We evaluated multiplicative interactions (pMI) and additive interactions (relative excess risk from interaction (pRERI), attributable proportion (pAR), synergy index (pSI)) with obese (BMI ≥30 kg/m2) and diabetes. Results During a mean follow‐up of 10.3 years, 9417 incident prostate cancers were diagnosed in 195,813 men …

Authors

Sofia Christakoudi,Konstantinos K Tsilidis,Evangelos Evangelou,Elio Riboli

Journal

Cancer Medicine

Published Date

2024/1/17

Association of atopic dermatitis with depression and sleep quality in an Asian general population cohort of 8887 participants

Association of atopic dermatitis with depression and sleep quality in an Asian general population cohort of 8887 participants Association of atopic dermatitis with depression and sleep quality in an Asian general population cohort of 8887 participants J Eur Acad Dermatol Venereol. 2024 Feb 19. doi: 10.1111/jdv.19836. Online ahead of print. Authors Yik Weng Yew 1 2 , Bill Rong Qin Chang 2 , Theresia Mina 2 , Elio Riboli 2 3 , Eng Sing Lee 2 4 , Joanne Ngeow 2 5 , Paul Elliott 2 3 , John C Chambers 2 3 , Jimmy Lee 2 6 , Marie Loh 1 2 3 7 Affiliations 1 National Skin Centre, Singapore City, Singapore. 2 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore. 3 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. 4 Clinical Research Unit, National Healthcare Group Polyclinic, Singapore City, Singapore. 5 Division of …

Authors

Yik Weng Yew,Bill Rong Qin Chang,Theresia Mina,Elio Riboli,Eng Sing Lee,Joanne Ngeow,Paul Elliott,John C Chambers,Jimmy Lee,Marie Loh

Journal

Journal of the European Academy of Dermatology and Venereology: JEADV

Published Date

2024/2/19

Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition

In this study, we aimed to provide novel evidence on the impact of changing lifestyle habits on cancer risk. In the EPIC cohort, 295,865 middle-aged participants returned a lifestyle questionnaire at baseline and during follow-up. At both timepoints, we calculated a healthy lifestyle index (HLI) score based on cigarette smoking, alcohol consumption, body mass index and physical activity. HLI ranged from 0 (most unfavourable) to 16 (most favourable). We estimated the association between HLI change and risk of lifestyle-related cancers—including cancer of the breast, lung, colorectum, stomach, liver, cervix, oesophagus, bladder, and others—using Cox regression models. We reported hazard ratios (HR) with 95% confidence intervals (CI). Median time between the two questionnaires was 5.7 years, median age at follow-up questionnaire was 59 years. After the follow-up questionnaire, we observed 14,933 lifestyle …

Authors

Edoardo Botteri,Giulia Peveri,Paula Berstad,Vincenzo Bagnardi,Geir Hoff,Alicia K Heath,Amanda J Cross,Paolo Vineis,Laure Dossus,Mattias Johansson,Heinz Freisling,Komodo Matta,Inge Huybrechts,Sairah LF Chen,Kristin B. Borch,Torkjel M Sandanger,Therese H. Nøst,Christina C Dahm,Christian S Antoniussen,Sandar Tin Tin,Agnès Fournier,Chloé Marques,Fanny Artaud,Maria-José Sánchez,Marcela Guevara,Carmen Santiuste,Antonio Agudo,Rashmita Bajracharya,Verena Katzke,Fulvio Ricceri,Claudia Agnoli,Manuela M Bergmann,Matthias B Schulze,Salvatore Panico,Giovanna Masala,Anne Tjønneland,Anja Olsen,Tanja Stocks,Jonas Manjer,Amaia Aizpurua-Atxega,Elisabete Weiderpass,Elio Riboli,Marc J Gunter,Pietro Ferrari

Journal

European Journal of Epidemiology

Published Date

2024/1/5

Links between the genetic determinants of morning plasma cortisol and body shape: a two-sample Mendelian randomisation study

High cortisol production in Cushing’s syndrome leads to fat centralisation. The influence of modest cortisol variations on body shape, however, is less clear. We examined potentially causal associations between morning plasma cortisol and body shape and obesity with inverse-variance weighted random-effects models in a two-sample Mendelian randomisation analysis. We used publicly available summary statistics from the CORtisol NETwork (CORNET) consortium, UK Biobank, and the Genetic Investigation of Anthropometric Traits (GIANT) consortium. Only in women, morning plasma cortisol (proxied by ten genetic polymorphisms) was associated positively with waist size reflected in waist-to-hip index (WHI, 0.035 standard deviation (SD) units change per one SD cortisol increase; 95% confidence interval (0.002–0.067); p = 0.036) and “a body shape index” (ABSI; 0.039 (0.006–0.071); p = 0.021). There was …

Authors

Sofia Christakoudi,Alexandros-Georgios Asimakopoulos,Elio Riboli,Konstantinos K Tsilidis

Journal

Scientific Reports

Published Date

2024/2/8

Temporal trajectories of COVID-19 symptoms in adults with 22 months follow-up in a prospective cohort study in Norway.

Objectives We aimed to describe the trajectories of cognitive and physical symptoms before, during, and after a positive- or negative SARS-CoV-2 test and in untested controls. Design A prospective cohort study. Setting Norway, 27 March 2020 to 6 July 2022 Participants A total of 146 065 volunteers were recruited. Of these, 120 605 participants (mean age 49 (SD 13.7), 69% female), were initially untested for the SARS-CoV-2 virus, completed one or more follow-up questionnaires (response rates 72-90%) and were included for analysis. After 22 months of follow-up, 15 737 participants had a positive SARS-CoV-2 test, 67 305 a negative test, and 37 563 were still untested. Main outcome measures We assessed reported symptoms the past three weeks of memory or concentration problems, anosmia and dysgeusia, dyspnoea, fatigue, fever, headache, cough, muscular pain, nasal symptoms, sore throat and abdominal pain at baseline and through four follow-up questionnaires. In addition, overall health compared to a year before was measured with a five-point scale and memory problems were measured using the Everyday Memory Questionnaire-13 at two timepoints. The exposure, SARS-CoV-2 test status (positive, negative or untested), was obtained from a mandatory national registry or from self-report, and data were analysed using mixed model logistic regression. Results A positive SARS-CoV-2-test was associated with the following persistent symptoms, compared with participants with a negative test (1-3 months after a negative test); memory problems (3 to 6 months after a positive test: adjusted odds ratio (OR) 9.1, 95% confidence …

Authors

Merete Ellingjord-Dale,Anders Nygaard,Nathalie Stoer,Ragnhild Boe,Nils Inge Landroe,Sonja Hjellegjerde Brunvoll,Mette Istre,Karl Trygve Kalleberg,John Arne Dahl,Linda Geng,Konstantinos Tsilidis,Elio Riboli,Giske Ursin,Arne Soeraas

Journal

medRxiv

Published Date

2024

academic-engine

Useful Links